Calgary, Canada Clinical Trials

A listing of Calgary, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)

The study is intended to show superiority of AZD9833 in combination with CDK4/6 inhibitor (palbociclib or abemaciclib) versus aromatase inhibitors (anastrozole or letrozole) in combination with CDK4/6 inhibitor in patients with hormone receptor-positive (HR-positive), human epidermal growth factor receptor 2-negative (HER2-negative) metastatic breast cancer with detectable ESR1 mutation

Research Site
 (2.9 away) Contact site
  • 1 views
  • 01 Aug, 2021
  • +84 other locations
Trial of PDE4 Inhibition With Roflumilast for the Management of Seborrheic Dermatitis (STRATUM)

The study will assess the safety and efficacy of ARQ-154 foam vs vehicle applied once for 8 weeks by subjects with seborrheic dermatitis.

erythema
Arcutis Biotherapeutics Clinical Site 35
 (4.9 away) Contact site
  • 0 views
  • 04 Aug, 2021
  • +48 other locations
Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

The purpose of this study is to compare the efficacy and safety of intravenous (IV) infusions of MT-3921 to placebo in subjects with acute traumatic cervical spinal cord injury. Subjects meeting eligibility criteria will enter the 6-month double-blind period. Subjects will be randomized in a 2:1 ratio to receive MT-3921 …

cervical spinal cord injury
spinal cord disorder
spinal cord
body mass index
University of Calgary Foothills Medical Centre
 (2.9 away) Contact site
  • 0 views
  • 04 Aug, 2021
  • +54 other locations
Nasal Poly-ICLC (Hiltonol ) in Healthy COVID-19 Vaccinated Adults

This is a randomized (4:1) Phase 1 b safety trial in adults who have completed their full COVID-19 vaccination schedule at least 30 days prior to study entry.

Health Research Innovation Centre
 (3.0 away) Contact site
  • 0 views
  • 30 Jul, 2021
  • 1 location
Closed-loop Insulin Delivery In Type 1 Diabetes Pregnancies (CIRCUIT) - Internal Pilot

This internal pilot trial will assess the feasibility and safety of a randomized controlled trial using the Tandem t:slim X2 pump with Control IQ technology in pregnant women with T1D. If funding for a larger multi-centre trial is obtained, the effects of using the Tandem t:slim X2 pump with Control …

insulin
injection of insulin
diabetes
University of Calgary
 (3.0 away) Contact site
  • 0 views
  • 30 Jul, 2021
  • +1 other locations
An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

This is a clinical study in adult participants with moderate to severe atopic dermatitis (AD). The purpose of the study is to test a new medicine (LEO 138559) given by injection to see if it works to treat AD and what the side effects are when compared with a placebo …

topical agents
eczema
LEO Investigational Site
 (2.8 away) Contact site
  • 0 views
  • 02 Aug, 2021
  • +9 other locations